Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001193125-24-239641
Filing Date
2024-10-18
Accepted
2024-10-18 16:15:26
Documents
1
Group Members
FORBION GROWTH MANAGEMENT B.V.FORBION GROWTH OPPORTUNITIES FUND I COOPERATIEF U.A.

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d889944dsc13da.htm SC 13D/A 99859
  Complete submission text file 0001193125-24-239641.txt   101528
Mailing Address GOOIMEER 2 35, NAARDEN P7 1411DC
Business Address GOOIMEER 2 35, NAARDEN P7 1411DC 31 35 6993015
Forbion Growth Sponsor FEAC I B.V. (Filed by) CIK: 0001897943 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address 4868 RUE LEVY, SUITE 220 SAINT-LAURENT A8 H4R 2P1
Business Address 4868 RUE LEVY, SUITE 220 SAINT-LAURENT A8 H4R 2P1 (514) 332-4888
enGene Holdings Inc. (Subject) CIK: 0001980845 (see all company filings)

EIN.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1031
Type: SC 13D/A | Act: 34 | File No.: 005-94211 | Film No.: 241380938
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)